165 related articles for article (PubMed ID: 20133228)
1. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.
Huang YQ; Xu F; Yang JM; Huang B
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):44-8. PubMed ID: 20133228
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
[TBL] [Abstract][Full Text] [Related]
5. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
7. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
8. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
9. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
10. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
Bartolozzi C; Lencioni R; Armillotta N
Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645
[TBL] [Abstract][Full Text] [Related]
11. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
12. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
14. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
Lin Z; Ren Z; Xia J
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive sequential interventional therapy for hepatocellular carcinoma.
Zhang L; Fan WJ; Huang JH; Li CX; Zhao M; Wang LG; Tang T
Chin Med J (Engl); 2009 Oct; 122(19):2292-8. PubMed ID: 20079128
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous cryoablation after chemoembolization of liver carcinoma: report of 34 cases.
Qian GJ; Chen H; Wu MC
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):520-4. PubMed ID: 14627512
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
[TBL] [Abstract][Full Text] [Related]
18. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]